Active substances
Calcium carbonate + Famotidine + Magnesium hydroxide
- US FDA 3
- Health Canada 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| PEPCID COMPLETE | 800MG;10MG;165MG | tablet, chewable · oral | KENVUE BRANDS | Over-the-counter | 16 Oct 2000 |
| FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | tablet, chewable · oral | PERRIGO R AND D | Over-the-counter | 6 Feb 2008 |
| FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | tablet, chewable · oral | PERRIGO R AND D | Discontinued | 29 Aug 2016 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| PEPCID COMPLETE | 02243053 | 800 MG; 165 MG; 10 MG | TABLET (CHEWABLE) · ORAL | KENVUE CANADA INC. |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.